ArticleSexually transmitted diseases2026
Implementation and Innovation in Syphilis Diagnostics: Insights from Global Health Systems, Molecular Testing, and Self-Testing Strategies.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overview of the Shanghai International Syphilis Symposium (SISS 2025).Sexually transmitted diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSyphilis remains a persistent global public health problem. Given that low-cost diagnostics and highly effective therapies have been available for decades, the current epidemic is driven by structural weaknesses in health systems, stigma, absence of political will and failures to integrate new technologies into routine care.
methodsAt the Shanghai 2025 Syphilis Meeting, experts highlighted the evolving landscape of syphilis diagnostics. The presentations offered an overview of our changing understanding of seronegative primary disease, reinfection patterns, and asymptomatic mucosal shedding as well as the limitations of diagnostics for neurosyphilis and novel approaches that have shown promising performance.
resultsOne presentation provided new insights into congenital syphilis by demonstrating significant changes seen on fetal ultrasound and compelling data suggesting a role for new point-of-care IgM tests for risk stratification of exposed newborns. Self-testing was highlighted as an emerging strategy that leverages community engagement, decentralization, and digital technologies to reach populations historically excluded from facility-based services. Finally, a global systems-level overview offered a summary of implementation barriers for diagnostic assays, the need for sustainable adoption of point-of-care tests, and the policy deficits that impede progress.
conclusionThe presentations collectively illustrated the complex interplay between technology, systems design, behavioral dynamics, and policy in shaping the global response to syphilis. The path forward requires an approach that integrates novel diagnostic and digital technologies with programs designed to strengthen health systems as well as community partnerships. Such cross-disciplinary frameworks have the potential to reduce diagnostic inequities and accelerate progress toward the elimination of syphilis worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.